BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 19020900)

  • 1. Neurofibromatosis type 1-related gastrointestinal stromal tumors: a special reference to loss of heterozygosity at 14q and 22q.
    Yamamoto H; Tobo T; Nakamori M; Imamura M; Kojima A; Oda Y; Nakamura N; Takahira T; Yao T; Tsuneyoshi M
    J Cancer Res Clin Oncol; 2009 Jun; 135(6):791-8. PubMed ID: 19020900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterozygosity loss at 22q and lack of INI1 gene mutation in gastrointestinal stromal tumor.
    Yamamoto H; Kohashi K; Tsuneyoshi M; Oda Y
    Pathobiology; 2011; 78(3):132-9. PubMed ID: 21613800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity on chromosome 22q in gastrointestinal stromal tumors (GISTs): a study on 50 cases.
    Lasota J; Wozniak A; Kopczynski J; Dansonka-Mieszkowska A; Wasag B; Mitsuhashi T; Sarlomo-Rikala M; Lee JR; Schneider-Stock R; Stachura J; Limon J; Miettinen M
    Lab Invest; 2005 Feb; 85(2):237-47. PubMed ID: 15580284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic loss of 14q and 22q, NF2 mutation, and genetic instability occur independently of c-kit mutation in gastrointestinal stromal tumor.
    Fukasawa T; Chong JM; Sakurai S; Koshiishi N; Ikeno R; Tanaka A; Matsumoto Y; Hayashi Y; Koike M; Fukayama M
    Jpn J Cancer Res; 2000 Dec; 91(12):1241-9. PubMed ID: 11123422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA expression profile of gastrointestinal stromal tumors is distinguished by 14q loss and anatomic site.
    Choi HJ; Lee H; Kim H; Kwon JE; Kang HJ; You KT; Rhee H; Noh SH; Paik YK; Hyung WJ; Kim H
    Int J Cancer; 2010 Apr; 126(7):1640-50. PubMed ID: 19795448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitotic recombination as evidence of alternative pathogenesis of gastrointestinal stromal tumours in neurofibromatosis type 1.
    Stewart DR; Corless CL; Rubin BP; Heinrich MC; Messiaen LM; Kessler LJ; Zhang PJ; Brooks DG
    J Med Genet; 2007 Jan; 44(1):e61. PubMed ID: 17209131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal stromal tumors of neurofibromatosis type I (von Recklinghausen's disease).
    Takazawa Y; Sakurai S; Sakuma Y; Ikeda T; Yamaguchi J; Hashizume Y; Yokoyama S; Motegi A; Fukayama M
    Am J Surg Pathol; 2005 Jun; 29(6):755-63. PubMed ID: 15897742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple gastrointestinal stromal tumors: Clinicopathologic and genetic analysis of 12 patients.
    Kang DY; Park CK; Choi JS; Jin SY; Kim HJ; Joo M; Kang MS; Moon WS; Yun KJ; Yu ES; Kang H; Kim KM
    Am J Surg Pathol; 2007 Feb; 31(2):224-32. PubMed ID: 17255767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis.
    Miettinen M; Lasota J
    Arch Pathol Lab Med; 2006 Oct; 130(10):1466-78. PubMed ID: 17090188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quadruple-Negative GIST Is a Sentinel for Unrecognized Neurofibromatosis Type 1 Syndrome.
    Gasparotto D; Rossi S; Polano M; Tamborini E; Lorenzetto E; Sbaraglia M; Mondello A; Massani M; Lamon S; Bracci R; Mandolesi A; Frate E; Stanzial F; Agaj J; Mazzoleni G; Pilotti S; Gronchi A; Dei Tos AP; Maestro R
    Clin Cancer Res; 2017 Jan; 23(1):273-282. PubMed ID: 27390349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs).
    Lasota J; Miettinen M
    Semin Diagn Pathol; 2006 May; 23(2):91-102. PubMed ID: 17193822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs.
    Martinho O; Gouveia A; Viana-Pereira M; Silva P; Pimenta A; Reis RM; Lopes JM
    Histopathology; 2009 Jul; 55(1):53-62. PubMed ID: 19614767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
    Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E
    Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activated targets of mTOR signaling pathway are characteristic for PDGFRA mutant and wild-type rather than KIT mutant GISTs.
    Sápi Z; Füle T; Hajdu M; Matolcsy A; Moskovszky L; Márk A; Sebestyén A; Bodoky G
    Diagn Mol Pathol; 2011 Mar; 20(1):22-33. PubMed ID: 21326036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interstitial cells of Cajal do not harbor c-kit or PDGFRA gene mutations in patients with sporadic gastrointestinal stromal tumors.
    Nakajima T; Miwa S; Ando T; Fujinami H; Kajiura S; Hosokawa A; Takano Y; Sugiyama T
    J Gastroenterol; 2009; 44(5):426-31. PubMed ID: 19333543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
    Miettinen M; Sobin LH; Lasota J
    Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Status and clinical implication of c-kit and PDGFRA mutations in 165 cases of gastrointestinal stromal tumor (GIST)].
    He HY; Fang WG; Zhong HH; Li Y; Zheng J; Du J; Heng WJ; Wu BQ
    Zhonghua Bing Li Xue Za Zhi; 2006 May; 35(5):262-6. PubMed ID: 16776995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of KIT and platelet-derived growth factor receptor alpha mutations with gene activation and expression profiles in gastrointestinal stromal tumors.
    Kang HJ; Nam SW; Kim H; Rhee H; Kim NG; Kim H; Hyung WJ; Noh SH; Kim JH; Yun CO; Liu ET; Kim H
    Oncogene; 2005 Feb; 24(6):1066-74. PubMed ID: 15690055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic aberrations of gastrointestinal stromal tumors.
    Yang J; Du X; Lazar AJ; Pollock R; Hunt K; Chen K; Hao X; Trent J; Zhang W
    Cancer; 2008 Oct; 113(7):1532-43. PubMed ID: 18671247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal neurofibromatosis is a subtype of familial GIST and results from a dominant activating mutation in PDGFRA.
    de Raedt T; Cools J; Debiec-Rychter M; Brems H; Mentens N; Sciot R; Himpens J; de Wever I; Schöffski P; Marynen P; Legius E
    Gastroenterology; 2006 Dec; 131(6):1907-12. PubMed ID: 17087943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.